Printer Friendly
The Free Library
7,774,290 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

B. Braun Launches DUPLEX(R) for Use with CeFOXItin; Company Now Shipping the Only Premium I.V. Drug Delivery System Available for CeFOXItin Therapy in U.S.


BETHLEHEM, Pa. -- B. Braun Medical Inc., a global leader in innovative healthcare products and services, today announced the launch of CeFOXItin 1g and 2g for injection in the DUPLEX(R) Drug Delivery System. Approved for use with CeFOXItin by the U.S. Food and Drug Administration (FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
) on March 10, 2006, DUPLEX is now the only ready-to-use IV drug delivery system available for CeFOXItin therapy in the United States.

"DUPLEX fills an immediate need for hospitals across the country with a simple, ready-to-use formula for this critical antibiotic therapy, enabling caretakers to provide the highest standard of care for their patients," said Rick Williamson, Director of Marketing, Drug Delivery, B. Braun Medical Inc. "DUPLEX reduces the potential for medication dosing errors with a unique barcode technology that references final admixture, can be used to automate patient charting, and is designed to fit into medication dispensing systems to track inventory and facilitate reimbursement."

DUPLEX is designed to help pharmacists and clinicians comply with Joint Commission on Accreditation and Healthcare Organizations (JCAHO JCAHO Joint Commission on Accreditation of Healthcare Organizations, see there ) and USP USP - unique sales point  797 Guidelines, which specify that medicines should be dispensed in their "most ready-to-use form." The DUPLEX Drug Delivery System is a closed system to ensure sterility and dose accuracy. It consists of a pre-filled, PVC-, DEHP-, and latex-free IV container that includes accurate doses of drug and diluent diluent /dil·u·ent/ (dil´oo-int)
1. causing dilution.

2. an agent that dilutes or renders less potent or irritant.


dil·u·ent
adj.
Serving to dilute.

n.
 in different compartments, separated by a quick release seal. There are no vials to attach or activate, and there is no possibility of delivering the diluent without the drug. Prior to activation, it can be stored at room temperature for up to 18 months and does not require a thawing process.

"Having a premium system for CeFOXItin on formulary formulary /for·mu·lary/ (for´mu-lar?e) a collection of recipes, formulas, and prescriptions.

National Formulary  see under N.


for·mu·lar·y
n.
 is a real economic benefit for the hospital," said James Abberton, M.S., R.Ph., Director of Pharmacy, Long Island Jewish Medical Center Long Island Jewish Medical Center (LIJMC) shares the title of clinical and academic hub of the North Shore-Long Island Jewish Health System. It is an 827-bed voluntary, non-profit tertiary care teaching hospital serving the greater metropolitan New York area. , New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
. "Its ready-to-use packaging and extended storage capacity reduces preparation time and provides hospital staff added flexibility for distribution and administration. Patients receive the right medication when they need it and without the complications associated with frozen or mixed solutions."

With the addition of CeFOXItin to its DUPLEX portfolio, B. Braun now offers a broad range of intravenous cephalosporin cephalosporin (sĕf'əlōspôr`ĭn), any of a group of more than 20 antibiotics derived from species of fungi of the genus Cephalosporium and closely related chemically to penicillin. Cephalosporins, e.g.  antibiotic therapies for the hospital and outpatient settings, covering the first three generations of cephalosporins Cephalosporins Definition

Cephalosporins are medicines that kill bacteria or prevent their growth.
Purpose

Cephalosporins are used to treat infections in different parts of the body—the ears, nose, throat, lungs, sinuses, and
: Cefazolin, CeFOXItin, CefuROXIme and CefTRIaxONE ceftriaxone /cef·tri·ax·one/ (cef?tri-ak´son) a semisynthetic, ß–resistant, third-generation cephalosporin effective against a wide range of gram-positive and gram-negative bacteria, used as the sodium salt. .

B. Braun is currently assisting customers with order placement and/or questions regarding DUPLEX for use with CeFOXItin. The Company can be reached at 1-800-BBRAUN-2 (800-227-2862).

About B. Braun

Since its founding in 1839, B. Braun has built an unparalleled store of knowledge and expertise in delivering innovative healthcare products, medical devices and programs that enhance both patient and health-professional safety. Its 30,000 employees worldwide are proud of their commitment to translating customer needs into products with unmatched quality, superior technology, cost-effectiveness and environmental responsibility.

Through its Sharing Expertise(R) initiative, B. Braun promotes best practices for continuous improvement of healthcare products and services. For more information about B. Braun or its safety healthcare products, call 800-854-6851, email us at inquiry@bbraun.com or visit B. Braun at www.bbraunusa.com.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:B. Braun Launches DUPLEX(R) for Use with CeFOXItin; Company Now Shipping the Only Premium I.V.
Publication:Business Wire
Article Type:Company overview
Geographic Code:1USA
Date:Jun 26, 2006
Words:514
Previous Article:INTRINSIC Semiconductor to be Acquired by Cree.
Next Article:Deutsche Bank Lists DB Commodity Index Tracking Fund in Mexico on the Bolsa Mexicana De Valores.
Topics:



Related Articles
Century-old bugs resist modern drugs.
Alliterative prescriptions pose problems. (similar spellings of cephalosporin derivatives) (Biomedicine)
Primary liver abscess caused by one clone of Klebsiella pneumoniae with two colonial morphotypes and resistotypes. (Dispatches).(Statistical Data...
Cefepime MIC as a predictor of the extended-spectrum [beta]-lactamase type in Klebsiella pneumoniae, Taiwan. (Dispatches).
Antimicrobial resistance of Escherichia coli O26, O103, O111, O128, and O145 from animals and humans. (Research).
Bacteremia due to Comamonas species possibly associated with exposure to tropical fish.(Case Report)
Cephamycin resistance in Clinical isolates and laboratory-derived strains of Escherichia coil, Nova Scotia, Canada.(Research)
Fluoroquinolone resistance linked to GyrA, GyrB, and ParC mutations in Salmonella enterica Typhimurium isolates in humans.(Dispatches)
[beta]-lactam resistance and enterobacteriaceae, United States.(DISPATCHES)
Population-based laboratory surveillance for AmpC [beta]-lactamase-producing Escherichia coli, Calgary.(RESEARCH)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles